Copyright Reports & Markets. All rights reserved.

Global Ischemia Reperfusion Injury Therapeutics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Ischemia Reperfusion Injury Therapeutics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by Product
      • 1.4.2 ANV-6L15
      • 1.4.3 APP-103
      • 1.4.4 BAY-606583
      • 1.4.5 EP-80317
      • 1.4.6 GS-459679
      • 1.4.7 KN-93
      • 1.4.8 LH-021
      • 1.4.9 Others
    • 1.5 Market by End User
      • 1.5.1 Global Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Ischemia Reperfusion Injury Therapeutics Market Size
      • 2.1.1 Global Ischemia Reperfusion Injury Therapeutics Revenue 2014-2025
      • 2.1.2 Global Ischemia Reperfusion Injury Therapeutics Sales 2014-2025
    • 2.2 Ischemia Reperfusion Injury Therapeutics Growth Rate by Regions
      • 2.2.1 Global Ischemia Reperfusion Injury Therapeutics Sales by Regions
      • 2.2.2 Global Ischemia Reperfusion Injury Therapeutics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Ischemia Reperfusion Injury Therapeutics Sales by Manufacturers
      • 3.1.1 Ischemia Reperfusion Injury Therapeutics Sales by Manufacturers
      • 3.1.2 Ischemia Reperfusion Injury Therapeutics Sales Market Share by Manufacturers
      • 3.1.3 Global Ischemia Reperfusion Injury Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Ischemia Reperfusion Injury Therapeutics Revenue by Manufacturers
      • 3.2.1 Ischemia Reperfusion Injury Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Ischemia Reperfusion Injury Therapeutics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Ischemia Reperfusion Injury Therapeutics Price by Manufacturers
    • 3.4 Ischemia Reperfusion Injury Therapeutics Manufacturing Base Distribution, Product Types
      • 3.4.1 Ischemia Reperfusion Injury Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Ischemia Reperfusion Injury Therapeutics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Ischemia Reperfusion Injury Therapeutics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Ischemia Reperfusion Injury Therapeutics Sales by Product
    • 4.2 Global Ischemia Reperfusion Injury Therapeutics Revenue by Product
    • 4.3 Ischemia Reperfusion Injury Therapeutics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Ischemia Reperfusion Injury Therapeutics Breakdown Data by End User

    6 North America

    • 6.1 North America Ischemia Reperfusion Injury Therapeutics by Countries
      • 6.1.1 North America Ischemia Reperfusion Injury Therapeutics Sales by Countries
      • 6.1.2 North America Ischemia Reperfusion Injury Therapeutics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Ischemia Reperfusion Injury Therapeutics by Product
    • 6.3 North America Ischemia Reperfusion Injury Therapeutics by End User

    7 Europe

    • 7.1 Europe Ischemia Reperfusion Injury Therapeutics by Countries
      • 7.1.1 Europe Ischemia Reperfusion Injury Therapeutics Sales by Countries
      • 7.1.2 Europe Ischemia Reperfusion Injury Therapeutics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Ischemia Reperfusion Injury Therapeutics by Product
    • 7.3 Europe Ischemia Reperfusion Injury Therapeutics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Ischemia Reperfusion Injury Therapeutics by Countries
      • 8.1.1 Asia Pacific Ischemia Reperfusion Injury Therapeutics Sales by Countries
      • 8.1.2 Asia Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Ischemia Reperfusion Injury Therapeutics by Product
    • 8.3 Asia Pacific Ischemia Reperfusion Injury Therapeutics by End User

    9 Central & South America

    • 9.1 Central & South America Ischemia Reperfusion Injury Therapeutics by Countries
      • 9.1.1 Central & South America Ischemia Reperfusion Injury Therapeutics Sales by Countries
      • 9.1.2 Central & South America Ischemia Reperfusion Injury Therapeutics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Ischemia Reperfusion Injury Therapeutics by Product
    • 9.3 Central & South America Ischemia Reperfusion Injury Therapeutics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Ischemia Reperfusion Injury Therapeutics by Countries
      • 10.1.1 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Sales by Countries
      • 10.1.2 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Ischemia Reperfusion Injury Therapeutics by Product
    • 10.3 Middle East and Africa Ischemia Reperfusion Injury Therapeutics by End User

    11 Company Profiles

    • 11.1 Nyken B.V.
      • 11.1.1 Nyken B.V. Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.1.5 Nyken B.V. Recent Development
    • 11.2 Omeros Corporation
      • 11.2.1 Omeros Corporation Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.2.5 Omeros Corporation Recent Development
    • 11.3 Opsona Therapeutics Limited
      • 11.3.1 Opsona Therapeutics Limited Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.3.5 Opsona Therapeutics Limited Recent Development
    • 11.4 Orexo AB
      • 11.4.1 Orexo AB Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Orexo AB Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Orexo AB Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.4.5 Orexo AB Recent Development
    • 11.5 Pharming Group N.V.
      • 11.5.1 Pharming Group N.V. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.5.5 Pharming Group N.V. Recent Development
    • 11.6 PledPharma AB
      • 11.6.1 PledPharma AB Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 PledPharma AB Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 PledPharma AB Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.6.5 PledPharma AB Recent Development
    • 11.7 Prolong Pharmaceuticals
      • 11.7.1 Prolong Pharmaceuticals Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.7.5 Prolong Pharmaceuticals Recent Development
    • 11.8 Proteo, Inc.
      • 11.8.1 Proteo, Inc. Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.8.5 Proteo, Inc. Recent Development
    • 11.9 Prothix BV
      • 11.9.1 Prothix BV Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Prothix BV Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Prothix BV Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.9.5 Prothix BV Recent Development
    • 11.10 Stealth BioTherapeutics Inc.
      • 11.10.1 Stealth BioTherapeutics Inc. Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Products Offered
      • 11.10.5 Stealth BioTherapeutics Inc. Recent Development
    • 11.11 Zealand Pharma A/S
    • 11.12 Amyndas Pharmaceuticals LLC
    • 11.13 Angion Biomedica Corp.
    • 11.14 Antipodean Pharmaceuticals, Inc.
    • 11.15 Bayer AG
    • 11.16 Biomedica Management Corporation
    • 11.17 Bolder Biotechnology, Inc.
    • 11.18 Curatis Pharma GmbH
    • 11.19 Ensemble Therapeutics Corporation
    • 11.20 Erimos Pharmaceuticals, LLC

    12 Future Forecast

    • 12.1 Ischemia Reperfusion Injury Therapeutics Market Forecast by Regions
      • 12.1.1 Global Ischemia Reperfusion Injury Therapeutics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Ischemia Reperfusion Injury Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.2 Ischemia Reperfusion Injury Therapeutics Market Forecast by Product
      • 12.2.1 Global Ischemia Reperfusion Injury Therapeutics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Ischemia Reperfusion Injury Therapeutics Revenue Forecast by Product 2019-2025
    • 12.3 Ischemia Reperfusion Injury Therapeutics Market Forecast by End User
    • 12.4 North America Ischemia Reperfusion Injury Therapeutics Forecast
    • 12.5 Europe Ischemia Reperfusion Injury Therapeutics Forecast
    • 12.6 Asia Pacific Ischemia Reperfusion Injury Therapeutics Forecast
    • 12.7 Central & South America Ischemia Reperfusion Injury Therapeutics Forecast
    • 12.8 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Ischemia Reperfusion Injury Therapeutics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Ischemia Reperfusion Injury Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ischemia Reperfusion Injury Therapeutics market based on company, product type, end user and key regions.

      This report studies the global market size of Ischemia Reperfusion Injury Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ischemia Reperfusion Injury Therapeutics in these regions.
      This research report categorizes the global Ischemia Reperfusion Injury Therapeutics market by top players/brands, region, type and end user. This report also studies the global Ischemia Reperfusion Injury Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Nyken B.V.
      Omeros Corporation
      Opsona Therapeutics Limited
      Orexo AB
      Pharming Group N.V.
      PledPharma AB
      Prolong Pharmaceuticals
      Proteo, Inc.
      Prothix BV
      Stealth BioTherapeutics Inc.
      Zealand Pharma A/S
      Amyndas Pharmaceuticals LLC
      Angion Biomedica Corp.
      Antipodean Pharmaceuticals, Inc.
      Bayer AG
      Biomedica Management Corporation
      Bolder Biotechnology, Inc.
      Curatis Pharma GmbH
      Ensemble Therapeutics Corporation
      Erimos Pharmaceuticals, LLC

      Market size by Product
      ANV-6L15
      APP-103
      BAY-606583
      EP-80317
      GS-459679
      KN-93
      LH-021
      Others
      Market size by End User
      Clinic
      Hospital
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Ischemia Reperfusion Injury Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Ischemia Reperfusion Injury Therapeutics market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Ischemia Reperfusion Injury Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Ischemia Reperfusion Injury Therapeutics submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Ischemia Reperfusion Injury Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ischemia Reperfusion Injury Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now